Tuesday, 28 February 2012

Licence application for teriflunomide filed in Europe

Source MS Trust:

Genzyme, the manufacturer of the disease modifying drug, teriflunomide (Aubagio), has submitted an application to the European Medicines Agency for a licence for relapsing remitting MS.  For more click here.